Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: A functional magnetic resonance study

Experimental Neurology

Volumn 235, Issue 1, 2012, Pages 256-264

  Enzi, Björn ^a   Edel, Marc Andreas ^a   Lissek, Silke ^b   Peters, Sören ^b   Hoffmann, Rainer ^c   Nicolas, Volkmar ^b   Tegenthoff, Martin ^b   Juckel, Georg ^a   Saft, Carsten ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Functional magnetic resonance imaging; Functional neuroimaging; Huntington's disease; Reward processing; Ventral striatum; Voxel based morphometry

Indexed keywords

ADULT; ANTICIPATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUNTINGTON CHOREA; MALE; MONETARY INCENTIVE DELAY TASK; MOTIVATION; MOTOR DYSFUNCTION; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; PROBABILITY; PUNISHMENT; REWARD; TASK PERFORMANCE; VOXEL BASED MORPHOMETRY; WHOLE BODY MRI;

ADULT; BASAL GANGLIA; BRAIN MAPPING; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PUNISHMENT; REWARD;

EID: 84859924202     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.02.003     Document Type: Article

References (48)

1. Aron A.R., Schlaghecken F., Fletcher P.C., Bullmore E.T., Eimer M., Barker R., Sahakian B.J., Robbins T.W. Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease. Brain 2003, 126:713-723.
2. Aylward E.H., Codori A., Barta P., Pearlson G., Harris G., Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington's disease. Arch. Neurol. 1996, 53:1293-1296.
3. Aylward E.H., Li Q., Stine O.C., Ranen N., Sherr M., Barta P.E., Bylsma F.W., Pearlson G., Ross C.A. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997, 48:394-399.
4. Aylward E.H., Nopoulos P.C., Ross C.A., Langbehn D.R., Pierson R.K., Mills J.A., Johnson H.J., Magnotta V.A., Juhl A.R., Paulsen J.S. Longitudinal change in regional brain volumes in prodromal Huntington disease. J. Neurol. Neurosurg. Psychiatry 2011, 82:405-410.
5. Bates G., Haper P., Jones L. Huntington's Disease 2002, Oxford University Press, Oxford. third ed.
6. Brett M., Anton J.-L., Valabregue R., Poline J.-B. Region of interest analysis using an SPM toolbox. Neuroimage 2002, 16(2).
7. DeGreck M., Rotte M., Paus R., Moritz D., Thiemann R., Proesch U., Bruer U., Moerth S., Tempelmann C., Bogerts B., Northoff G. Is our self based on reward? Self-relatedness recruits neural activity in the reward system. Neuroimage 2008, 39:2066-2075.
8. Dougherty D.M., Bjork J.M., Huckabee H.C.G., Moeller F.G., Swann A.C. Laboratory measures of aggression and impulsivity in woman with borderline personality disorder. Psychiatry Res. 1999, 85:315-326.
9. Enzi B., deGreck M., Prösch U., Tempelmann C., Northoff G. Is our self nothing but reward? Neuronal overlap and distinction between reward and personal relevance and its relation to human personality. Plos One 2009, 4:e8429.
10. Enzi B., Doering S., Faber C., Hinrichs J., Bahmer J., Northoff G. Reduced deactivation in reward circuitry and midline structures during emotion processing in borderline personality disorder. World J. Biol. Psychiatry 2011, 10.3109/15622975.2011.579162.
11. Friston K.J., Holmes A., Worsley K., Poline J.B., Frith C., Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 1994, 2:189-210.
12. Friston K.J., Fletcher P., Josephs O., Holmes A., Rugg M.D., Turner R. Event-related fMRI: characterizing differential responses. Neuroimage 1998, 7:30-40.
13. Genovese C., Lazar N., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878.
14. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35:4-26.
15. Harris G., Pearlson G., Peyser C.E., Aylward E.H., Roberts J., Barta P., Chase G.A., Folstein S. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann. Neurol. 1992, 31:69-75.
16. Henley S.M.D., Ridgway G.R., Scahill R.I., Klöppel S., Tabrizi S.J., Fox N.C., Kassubek J. Pitfalls in the use of voxel-based morphometry as a biomarker: examples from Huntington's disease. AJNR Am. J. Neuroradiol. 2010, 31:711-719.
17. Jensen J., Smith A.J., Willeit M., Crawley A.P., Mikulis D.J., Vitcu I., Kapur S. Separate brain regions code for salience vs. valence during reward prediciton in humans. Hum. Brain Mapp. 2007, 28:294-302.
18. Juckel G., Schlagenhauf F., Koslowski M., Wüstenberg T., Villringer A., Knutson B., Wrase J., Heinz A. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 2005, 29:409-416.
19. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reinforcement learning. Neurosci. Biobehav. Rev. 2004, 27:265-276.
20. Kipps C.M., Duggins A.J., Mahant N., Gomes L., Ashburner J., McCusker E.A. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J. Neurol. Neurosurg. Psychiatry 2005, 76:650-655.
21. Knutson B., Westdorp A., Kaiser E., Hommer D. Fmri visualization of brain activity during a monetary incentive delay task. Neuroimage 2000, 12:20-27.
22. Kriegeskorte N., Simmons W., Bellgowan P., Baker C. Circular analysis in systems neuroscience: the dangers of double dipping. Nat. Neurosci. 2009, 12:535-540.
23. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 2004, 65:267-277.
24. MacDonald P.A., Monchi O. Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. Parkinsons Dis. 2011, (ID 572743).
25. MacDonald P.A., MacDonald A.A., Seergobin K.N., Tamjeedi R., Ganjavi H., Provost J.S., Monchi O. The effect of dopamine therapy on ventral and dorsal striatum mediated cognition in Parkinson's disease: support from functional MRI. Brain 2011, 134:1447-1463.
26. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
27. Montague P.R., Berns G.S. Neural economics and the biological substrates of valuation. Neuron 2002, 36:265-284.
28. Montoya A., Price B.H., Menear M., Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J. Psychiatry Neurosci. 2006, 31:21-29.
29. Mühlau M., Gaser C., Wohlschläger A.M., Weindl A., Städtler M., Valet M., Zimmer C., Kassubek J., Peinemann A. Striatal gray matter loss in Huntington's disease is leftward biased. Mov. Disord. 2007, 22:1169-1201.
30. Mühlau M., Wohlschläger A.M., Gaser C., Valet M., Weindl A., Nunnemann S., Peinemann A., Etgen T., Ilg R. Voxel-based morphometry in individual patients: a pilot study in early Huntington disease. AJNR Am. J. Neuroradiol. 2009, 30:539-543.
31. Paulsen J.S. Functional imaging in Huntington's disease. Exp. Neurol. 2009, 216:272-277.
32. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., Reynolds N.C., Rao S.M. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. AJNR Am. J. Neuroradiol. 2004, 25:1715-1721.
33. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E.H., Ross C.A., Nance M., Guttman M., Johnson S., MacDonald M., Beglinger L.J., Duff K., Kayson E., Biglan K., Shoulson I., Oakes D., Hayden M. Detection of Huntington's disease decades before diagnosis: the Predict-HD-study. J. Neurol. Neurosurg. Psychiatry 2008, 79:874-880.
34. Postuma R.B., Dagher A. Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications. Cereb. Cortex 2006, 16:1508-1521.
35. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Pekar J.J., Pearlson G.D., Aylward E.H., Brandt J., Bassett S.S., Ross C.A. Funtional brain changes in presymptomatic Huntington's disease. Ann. Neurol. 2004, 55:879-883.
36. Rosas H.D., Feigin A.S., Hersch S.M. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx 2004, 1:263-272.
37. Saft C., Andrich J., Meisel N.M., Przuntek H., Muller T. Assessment of simple movements reflects impairment in Huntington's disease. Mov. Disord. 2006, 21:1208-1212.
38. Saft C., Schüttke A., Beste C., Andrich J., Heindel W., Pfleiderer B. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease. Neuropsychologia 2008, 46:1279-1289.
39. Ströhle A., Stoy M., Wrase J., Schwarz S., Schlagenhauf F., Huss M., Hein J., Nedderhut A., Neumann B., Gregor A., Juckel G., Knutson B., Lehmkuhl U., Bauer M., Heinz A. Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. Neuroimage 2008, 39:966-972.
40. Tabrizi S.J., Scahill R.I., Durr A., Ross R.A., Leavitt B.R., Jones R., Landwehrmeyer G.B., Fox N.C., Johnson H., Hicks S.L., Kennard C., Craufurd C., Frost C., Langbehn D.R., Reimann R., Stout J.C., TRACK-HD Investigators Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011, 10:31-42.
41. Thiruvady D.R., Georgiou-Karistianis N., Egan G.F., Ray S., Sritharan A., Farrow M., Churchyard A., Chua P., Bradshaw J.L., Brawn T.L., Cunnington R. Functional connectivity of the prefrontal cortex in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:127-133.
42. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 1985, 44:559-577.
43. Voorn P., Vanderschuren L.J.M.J., Groenewegen H.J., Robbins T.W., Pennartz C.M.A. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 2004, 27:468-474.
44. Weir D.W., Sturrock A., Leavitt B.R. Development of biomarkers for Huntington's disease. Lancet Neurol. 2011, 10:573-590.
45. Wolf R.C., Vasic N., Schönfeld-Lecuona C., Landwehrmeyer B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007, 130:2845-2857.
46. Wolf R.C., Sambataro F., Vasic N., Schönfeld-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp. Neurol. 2008, 213:137-144.
47. Wolf R.C., Sambataro F., Vasic N., Schönfeld-Lecuona C., Ecker D., Landwehrmeyer B. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load. Eur. J. Neurol. 2008, 15:1180-1190.
48. Zimbelman J.L., Paulsen J.S., Mikos A., Reynolds N.C., Hoffmann R.G., Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J. Int. Neuropsychol. Soc. 2007, 13:758-769.